These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 10792365)
1. Inhibition of CD23 processing correlates with inhibition of IL-4-stimulated IgE production in human PBL and hu-PBL-reconstituted SCID mice. Mayer RJ; Bolognese BJ; Al-Mahdi N; Cook RM; Flamberg PL; Hansbury MJ; Khandekar S; Appelbaum E; Faller A; Marshall LA Clin Exp Allergy; 2000 May; 30(5):719-27. PubMed ID: 10792365 [TBL] [Abstract][Full Text] [Related]
2. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist. Carballido JM; Schols D; Namikawa R; Zurawski S; Zurawski G; Roncarolo MG; de Vries JE J Immunol; 1995 Nov; 155(9):4162-70. PubMed ID: 7594571 [TBL] [Abstract][Full Text] [Related]
3. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilonRII). Christie G; Barton A; Bolognese B; Buckle DR; Cook RM; Hansbury MJ; Harper GP; Marshall LA; McCord ME; Moulder K; Murdock PR; Seal SM; Spackman VM; Weston BJ; Mayer RJ Eur J Immunol; 1997 Dec; 27(12):3228-35. PubMed ID: 9464810 [TBL] [Abstract][Full Text] [Related]
4. Effect of cytokines on spontaneous and allergen-induced CD23 expression, sCD23 release and Ig(E,G) synthesis from peripheral blood lymphocytes. Pfeil T; Fischer A; Bujanowski-Weber J; Luther H; Altmeyer P; König W Immunology; 1989 Sep; 68(1):37-44. PubMed ID: 2530155 [TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice. Spiegelberg HL; Beck L; Kocher HP; Fanslow WC; Lucas AH J Clin Invest; 1994 Feb; 93(2):711-7. PubMed ID: 8113405 [TBL] [Abstract][Full Text] [Related]
6. Regulation of human IgE response in hu-PBL-SCID mice. Kilchherr E; Mandak V; Wagner K; Heusser CH Cell Immunol; 1993 Oct; 151(2):241-56. PubMed ID: 8402934 [TBL] [Abstract][Full Text] [Related]
7. Regulation of CD23 expression, soluble CD23 release and immunoglobulin synthesis of peripheral blood lymphocytes by glucocorticoids. Fischer A; König W Immunology; 1990 Dec; 71(4):473-9. PubMed ID: 2149121 [TBL] [Abstract][Full Text] [Related]
8. Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE. Saxon A; Ke Z; Bahati L; Stevens RH J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):333-44. PubMed ID: 1698844 [TBL] [Abstract][Full Text] [Related]
10. In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain. Nakamura T; Kloetzer WS; Brams P; Hariharan K; Chamat S; Cao X; LaBarre MJ; Chinn PC; Morena RA; Shestowsky WS; Li YP; Chen A; Reff ME Int J Immunopharmacol; 2000 Feb; 22(2):131-41. PubMed ID: 10684997 [TBL] [Abstract][Full Text] [Related]
11. Soluble CD23 controls IgE synthesis and homeostasis in human B cells. Cooper AM; Hobson PS; Jutton MR; Kao MW; Drung B; Schmidt B; Fear DJ; Beavil AJ; McDonnell JM; Sutton BJ; Gould HJ J Immunol; 2012 Apr; 188(7):3199-207. PubMed ID: 22393152 [TBL] [Abstract][Full Text] [Related]
12. Cytokine control of peripheral-blood CD23 expression and sCD23 release: differential regulation by IL-2 and IL-4. Fischer A; Pfeil T; König W Int Arch Allergy Appl Immunol; 1990; 92(4):334-42. PubMed ID: 2150667 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Pène J; Rousset F; Brière F; Chrétien I; Wideman J; Bonnefoy JY; De Vries JE Eur J Immunol; 1988 Jun; 18(6):929-35. PubMed ID: 3260186 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of sCD23 and immunoglobulin E release from human B cells by a metalloproteinase inhibitor, GI 129471. Wheeler DJ; Parveen S; Pollock K; Williams RJ Immunology; 1998 Sep; 95(1):105-10. PubMed ID: 9767464 [TBL] [Abstract][Full Text] [Related]
15. Cell-cell interactions for CD23 expression and soluble CD23 release from peripheral lymphocytes of atopic donors. Kicza K; Fischer A; Pfeil T; Bujanowski-Weber J; König W Immunology; 1989 Dec; 68(4):532-9. PubMed ID: 2532620 [TBL] [Abstract][Full Text] [Related]
16. Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production. Scheffel F; Heine G; Henz BM; Worm M Inflamm Res; 2005 Mar; 54(3):113-8. PubMed ID: 15883744 [TBL] [Abstract][Full Text] [Related]
17. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes. Nonoyama S; Smith FO; Ochs HD J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809 [TBL] [Abstract][Full Text] [Related]
18. Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors. Bujanowski-Weber J; Brings B; Knöller I; Pfeil T; König W Immunology; 1989 Apr; 66(4):505-11. PubMed ID: 2523859 [TBL] [Abstract][Full Text] [Related]
19. Anti-CD23 monoclonal antibodies: comparisons of epitope specificities and modulating capacities for IgE binding and production. Wakai M; Pasley P; Sthoeger ZM; Posnett DN; Brooks R; Hashimoto S; Chiorazzi N Hybridoma; 1993 Feb; 12(1):25-43. PubMed ID: 7681036 [TBL] [Abstract][Full Text] [Related]
20. B cell activation and Ig, especially IgE, production is inhibited by high CD23 levels in vivo and in vitro. Cho SW; Kilmon MA; Studer EJ; van der Putten H; Conrad DH Cell Immunol; 1997 Aug; 180(1):36-46. PubMed ID: 9316637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]